• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细胞的慢性阻塞性肺疾病治疗。重建肺部。

Cell-based Therapy for Chronic Obstructive Pulmonary Disease. Rebuilding the Lung.

机构信息

University of Vermont, Burlington, Vermont.

出版信息

Ann Am Thorac Soc. 2018 Dec;15(Suppl 4):S253-S259. doi: 10.1513/AnnalsATS.201808-534MG.

DOI:10.1513/AnnalsATS.201808-534MG
PMID:30759002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6944395/
Abstract

As the prevalence and impact of lung diseases continue to increase worldwide, new therapeutic strategies are desperately needed. Advances in lung-regenerative medicine, a broad field encompassing stem cells, cell-based therapies, and a range of bioengineering approaches, offer new insights into and new techniques for studying lung physiology and pathophysiology. This provides a platform for the development of novel therapeutic approaches. Applicability to chronic obstructive pulmonary disease of recent advances and applications in cell-based therapies, predominantly those with mesenchymal stromal cell-based approaches, and bioengineering approaches for lung diseases are reviewed.

摘要

随着肺部疾病的患病率和影响在全球范围内不断增加,迫切需要新的治疗策略。肺再生医学领域的进展,涵盖了干细胞、基于细胞的疗法和一系列生物工程方法,为研究肺生理学和病理生理学提供了新的见解和技术。这为开发新的治疗方法提供了一个平台。本文综述了细胞疗法,尤其是基于间充质基质细胞的方法,以及用于肺部疾病的生物工程方法在慢性阻塞性肺疾病中的最新进展和应用。

相似文献

1
Cell-based Therapy for Chronic Obstructive Pulmonary Disease. Rebuilding the Lung.基于细胞的慢性阻塞性肺疾病治疗。重建肺部。
Ann Am Thorac Soc. 2018 Dec;15(Suppl 4):S253-S259. doi: 10.1513/AnnalsATS.201808-534MG.
2
Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.简明综述:干细胞与再生医学在肺生物学及疾病中的现状
Stem Cells. 2014 Jan;32(1):16-25. doi: 10.1002/stem.1506.
3
Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.将基础研究转化为安全有效的基于细胞的呼吸疾病治疗方法。
Ann Am Thorac Soc. 2019 Jun;16(6):657-668. doi: 10.1513/AnnalsATS.201812-890CME.
4
Potential role of stem cells in management of COPD.干细胞在 COPD 管理中的潜在作用。
Int J Chron Obstruct Pulmon Dis. 2010 Apr 7;5:81-8. doi: 10.2147/copd.s7373.
5
The clinical use of regenerative therapy in COPD.再生疗法在 COPD 中的临床应用。
Int J Chron Obstruct Pulmon Dis. 2014 Dec 12;9:1389-96. doi: 10.2147/COPD.S49519. eCollection 2014.
6
Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option.干细胞疗法治疗慢性阻塞性肺疾病:间充质干细胞作为一种有前途的治疗选择。
Stem Cell Res Ther. 2024 Sep 19;15(1):312. doi: 10.1186/s13287-024-03940-9.
7
Concise review: clinical prospects for treating chronic obstructive pulmonary disease with regenerative approaches.简明综述:再生方法治疗慢性阻塞性肺疾病的临床前景。
Stem Cells Transl Med. 2012 Aug;1(8):627-31. doi: 10.5966/sctm.2012-0065. Epub 2012 Jul 24.
8
Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches.肺再生:内源性和外源性干细胞介导的治疗方法
Int J Mol Sci. 2016 Jan 19;17(1):128. doi: 10.3390/ijms17010128.
9
[Regenerative approach for COPD].[慢性阻塞性肺疾病的再生治疗方法]
Nihon Rinsho. 2011 Oct;69(10):1869-72.
10
Tissue regeneration as next-generation therapy for COPD--potential applications.组织再生作为慢性阻塞性肺疾病的下一代治疗方法——潜在应用
Int J Chron Obstruct Pulmon Dis. 2008;3(4):509-14. doi: 10.2147/copd.s1092.

引用本文的文献

1
Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?用干细胞阻止 SARS-CoV2 感染:再生围产期组织间充质干细胞能否为 COVID-19 提供多方位的治疗方法?
Placenta. 2022 Jan;117:161-168. doi: 10.1016/j.placenta.2021.12.005. Epub 2021 Dec 6.
2
Effect of Hyaluronic Acid on the Differentiation of Mesenchymal Stem Cells into Mature Type II Pneumocytes.透明质酸对间充质干细胞向成熟II型肺上皮细胞分化的影响。
Polymers (Basel). 2021 Aug 30;13(17):2928. doi: 10.3390/polym13172928.
3
Allogeneic human umbilical cord-derived mesenchymal stem/stromal cells for chronic obstructive pulmonary disease (COPD): study protocol for a matched case-control, phase I/II trial.异体人脐带间充质干细胞治疗慢性阻塞性肺疾病(COPD):一项匹配病例对照、I/II 期临床试验研究方案。
BMJ Open. 2021 May 13;11(5):e045788. doi: 10.1136/bmjopen-2020-045788.
4
Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.间充质基质细胞输注对高 C 反应蛋白水平 COPD 患者肺功能的影响。
Respir Res. 2021 May 8;22(1):142. doi: 10.1186/s12931-021-01734-8.
5
Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?慢性肺病中新兴的细胞疗法:哮喘呢?
Front Pharmacol. 2021 Apr 20;12:648506. doi: 10.3389/fphar.2021.648506. eCollection 2021.
6
PLGA Nanofiber/PDMS Microporous Composite Membrane-Sandwiched Microchip for Drug Testing.用于药物检测的聚乳酸-羟基乙酸共聚物纳米纤维/聚二甲基硅氧烷微孔复合膜夹层微芯片
Micromachines (Basel). 2020 Nov 28;11(12):1054. doi: 10.3390/mi11121054.
7
Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease.靶向治疗慢性阻塞性肺疾病的衰老途径。
Int J Mol Sci. 2020 Sep 21;21(18):6924. doi: 10.3390/ijms21186924.
8
Comment on "Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study".评“同种异体脐带间充质干细胞移植治疗慢性阻塞性肺疾病:一项初步临床研究”。
Stem Cell Res Ther. 2020 Aug 5;11(1):340. doi: 10.1186/s13287-020-01859-5.
9
Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials.用于治疗新冠肺炎及其他呼吸道疾病的干细胞疗法:临床试验的全球趋势
World J Stem Cells. 2020 Jun 26;12(6):471-480. doi: 10.4252/wjsc.v12.i6.471.

本文引用的文献

1
Stem cell-based Lung-on-Chips: The best of both worlds?基于干细胞的肺芯片:两全其美?
Adv Drug Deliv Rev. 2019 Feb 1;140:12-32. doi: 10.1016/j.addr.2018.07.005. Epub 2018 Jul 25.
2
3D Printing in Pharmaceutical and Medical Applications - Recent Achievements and Challenges.3D 打印在制药和医疗应用中的应用——最新进展和挑战。
Pharm Res. 2018 Jul 11;35(9):176. doi: 10.1007/s11095-018-2454-x.
3
Macchiarini case: seven researchers are guilty of scientific misconduct, rules Karolinska's president.马基亚里尼事件:卡罗林斯卡学院院长裁定,七名研究人员存在科研不端行为。
BMJ. 2018 Jun 27;361:k2816. doi: 10.1136/bmj.k2816.
4
Avian lungs: A novel scaffold for lung bioengineering.禽类肺脏:肺生物工程的新型支架。
PLoS One. 2018 Jun 27;13(6):e0198956. doi: 10.1371/journal.pone.0198956. eCollection 2018.
5
Co-opting of ClinicalTrials.gov by patient-funded studies.患者资助研究对ClinicalTrials.gov的占用。
Lancet Respir Med. 2018 Aug;6(8):579-581. doi: 10.1016/S2213-2600(18)30242-X. Epub 2018 Jun 19.
6
Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling.开发用于生成肺组织以进行个性化疾病建模的三维生物工程技术。
Curr Protoc Stem Cell Biol. 2018 Aug;46(1):e56. doi: 10.1002/cpsc.56. Epub 2018 Jun 7.
7
Extracorporeal Gas Exchange.体外气体交换。
Crit Care Clin. 2018 Jul;34(3):413-422. doi: 10.1016/j.ccc.2018.03.011.
8
Acellular human lung scaffolds to model lung disease and tissue regeneration.细胞外人类肺支架用于模拟肺部疾病和组织再生。
Eur Respir Rev. 2018 Jun 6;27(148). doi: 10.1183/16000617.0021-2018. Print 2018 Jun 30.
9
Incorporating mechanical strain in organs-on-a-chip: Lung and skin.在芯片上的器官中引入机械应变:肺和皮肤。
Biomicrofluidics. 2018 May 21;12(4):042207. doi: 10.1063/1.5024895. eCollection 2018 Jul.
10
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.间质基质细胞:临床挑战与治疗机遇。
Cell Stem Cell. 2018 Jun 1;22(6):824-833. doi: 10.1016/j.stem.2018.05.004.